Ensuring. Viral Safety of Viral Vaccines and Vectors

被引：0

作者：

Boumlic, Anissa ^{[1
]}

Wisher, Martin ^{[2
]}

Asher, Damon ^{[3
]}

Pattnaik, Priyabrata ^{[4
]}

机构：

[1] MilliporeSigma, EMEA Vaccine & Viral Therapies, Burlington, MA 01803 USA

[2] MilliporeSigma, Regulatory Affairs BioReliance, Burlington, MA USA

[3] MilliporeSigma, Amer Vaccine & Viral Therapies, Burlington, MA USA

[4] MilliporeSigma, Biol Operat Asia Pacific, Burlington, MA USA

来源：

关键词：

HIGH-TEMPERATURE; INACTIVATION; VIRUS; IDENTIFICATION; CONTAMINATION; CLEARANCE;

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：36 / 42

页数：7

共 50 条

[1] Viral vectors for veterinary vaccines
Sheppard, M
ADVANCES IN VETERINARY MEDICINE, VOL 41: VETERINARY VACCINES AND DIAGNOSTICS, 1999, 41 : 145 - 161
[2] Virus safety for vaccines, viral vectors, and cell based therapies
Asher, Damon
Boumlic, Anissa
Pattnaik, Priyabrata
Wisher, Martin
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[3] Replicon RNA Viral Vectors as Vaccines
Lundstrom, Kenneth
VACCINES, 2016, 4 (04):
[4] ADENOVIRUS VECTORS AS RECOMBINANT VIRAL VACCINES
IMLER, JL
VACCINE, 1995, 13 (13) : 1143 - 1151
[5] Use of viral vectors for the development of vaccines
Liniger, Matthias
Zunija, Armando
Naim, Hussein Y.
EXPERT REVIEW OF VACCINES, 2007, 6 (02) : 255 - 266
[6] Viral vectors for gene therapy and vaccines
Glaser, V
GENETIC ENGINEERING NEWS, 2004, 24 (02): : 8 - 10
[7] Downstream processing of viral vectors and vaccines
Morenweiser, R
GENE THERAPY, 2005, 12 (Suppl 1) : S103 - S110
[8] Recombinant viral vectors: Cancer vaccines
Harrop, Richard
John, Justin
Carroll, Miles W.
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (08) : 931 - 947
[9] NONREPLICATING VIRAL VECTORS AS RECOMBINANT VACCINES
PAOLETTI, E
TARTAGLIA, J
TAYLOR, J
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) : 942 - 942
[10] Downstream processing of viral vectors and vaccines
R Morenweiser
Gene Therapy, 2005, 12 : S103 - S110